Pharmaceutical compositions useful for the treatment or control of bacterial infections, comprising effective amounts of: (a) at least one beta-lactam antibiotic agent or a pharmaceutically acceptable derivative thereof, (b) at least one beta-lactamase inhibitor or a pharmaceutically acceptable salt thereof, and (c) mecillinam or a pharmaceutically acceptable derivative thereof, wherein the beta-lactam antibiotic agent is a cephem compound are disclosed.